Abbreviations:mm Hg (pressure in millimeters of mercury), NYHA (New York Heart Association), PI (pulmonary valve insufficiency), RV (right ventricle), RVEDD (right ventricular end-diastolic diameter), RVOT (right ventricular outflow tract), SD (standard deviation), VSD (ventricular septal defect), XPV (Xeltis pulmonary valve conduit)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Seminars in Thoracic and Cardiovascular Surgery
- Performance of CryoValve SG decellularized pulmonary allografts compared with standard cryopreserved allografts.Ann Thorac Surg. 2009; 88: 849-855
- A novel restorative pulmonary valved conduit in a chronic sheep model: Mid-term hemodynamic function and histologic assessment.J Thorac Cardiovasc Surg. 2018; 155 (e3): 2591-2601
WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects – WMA – The World Medical Association n.d.
ISO - ISO 14155:2011 - Clinical investigation of medical devices for human subjects — Good clinical practice n.d.
- Comparison of doppler echocardiography with angiography for determining the severity of pulmonary regurgitation.Am J Cardiol. 2002; 89: 1438-1441
- Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography.J Am Soc Echocardiogr. 2003; 16: 777-802
- Homograft conduit failure in infants is not due to somatic outgrowth.J Thorac Cardiovasc Surg. 2002; 124: 88-96
FDA Executive Summary 020003 – prepared for the September 23, 2014 meeting of the FDA's Pediatric Advisory Committee, tables 2, 3 and 9. n.d.
Xeltis Bioabsorbable Pulmonary Valved Conduit Early Feasibility Study - Full Text View - ClinicalTrials.gov n.d.
- A novel restorative pulmonary valve conduit: early outcomes of two clinical trials.Front Cardiovasc Med - Accept Publ. 2021; https://doi.org/10.3389/fcvm.2020.583360
- The impact of pulmonary regurgitation on right ventricular size and function in patients with repaired tetralogy of Fallot and additional haemodynamic abnormalities.Polish J Radiol. 2020; 85: 607-612
Funding: This study was funded by an unrestricted research grant from Xeltis B.V. the Netherlands.
Conflicts of interest: Cox, Schutte and Svanidze are employees of, or hold shares/ options in Xeltis. Dr.Carrel is a member of the Advisory Board of Xeltis (without clinical involvement). F.Asch directs an academic cardiovascular imaging core laboratory with institutional contracts to Xeltis (with no personal conflict of interest). All other authors have nothing to disclose.
ClinicalTrials.gov No: NCT02700100
Regulatory approvals: Hungary: Authority: Health Registration and Training Center, Division of Medical Devices
Date: 06 June 2016
Poland: Authority: The Office for Registration of Medicinal Products, medical Devices and Biocidal Products
Date: 20 July 2016
Malaysia: Authority: Medical Device Authority, Ministry of Health Malaysia
Date: 20 Sept 2016